Jefferies Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jefferies Group’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$138K	–	2021
2022 Q2	$138K	Buy	+10,000	New	+$160K	﹤0.01%	1326
2022 Q1	–	Sell	-56,500	Closed	-$920K	–	2046
2021 Q4	$920K	Hold	56,500	–	–	0.01%	1019
2021 Q3	$839K	Buy	+56,500	New	+$904K	0.01%	1060
2021 Q1	–	Sell	-23,000	Closed	-$568K	–	2078
2020 Q4	$568K	Sell	23,000 -3,000	-12%	-$99.4K	﹤0.01%	1089
2020 Q3	$1.08M	Hold	26,000	–	–	0.01%	775
2020 Q2	$1.25K	Hold	26,000	–	–	0.01%	706
2020 Q1	$1.64M	Sell	26,000 -4,100	-14%	-$368K	0.02%	779
2019 Q4	$3.73M	Sell	30,100 -300	-1%	-$26.9K	0.03%	670
2019 Q3	$2.02M	Sell	30,400 -5,600	-16%	-$376K	0.02%	1077
2019 Q2	$2.87M	Buy	36,000 +13,600	+61%	+$1.22M	0.02%	741
2019 Q1	$2.51M	Buy	22,400 +15,400	+220%	+$1.68M	0.02%	787
2018 Q4	$706K	Buy	+7,000	New	+$726K	0.01%	1332
2018 Q1	–	Sell	-67,300	Closed	-$3.93M	–	2828
2017 Q4	$3.93M	Buy	67,300 +36,100	+116%	+$2.28M	0.02%	657
2017 Q3	$1.81M	Buy	+31,200	New	+$3.36M	0.01%	991
2017 Q1	–	Sell	-500	Closed	-$54K	–	2725
2016 Q4	$54K	Buy	+500	New	+$59.6K	﹤0.01%	2078
2015 Q1	–	Sell	-20,500	Closed	-$3.2M	–	2463
2014 Q4	$3.2M	Buy	20,500 +500	+3%	+$92.4K	0.02%	546
2014 Q3	$4.73M	Buy	20,000 +10,000	+100%	+$2.55M	0.03%	443
2014 Q2	$2.37M	Buy	+10,000	New	+$2.64M	0.02%	577

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jefferies Group's ICPT Position: Q1 2021 in Review

Jefferies Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 22,406 shares — an estimated $553K sold.

Jefferies Group first reported a position in ICPT in Q2 2014 and held it in 20 quarters. The position peaked at $15M in Q3 2017. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

Jefferies Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Jefferies Group sold 22,406 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $553K.
Jefferies Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 20 quarters.
Jefferies Group's Intercept Pharmaceuticals, Inc. position peaked at $15M in Q3 2017.
151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.